Kelyniam Global, Inc. (KLYG)

Market Cap	7.31M +96.6%
Revenue (ttm)	2.67M -8.0%
Net Income	-218.47K
EPS	-0.01
Shares Out	50.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,200
Open	0.1300
Previous Close	0.1500
Day's Range	0.1300 - 0.1500
52-Week Range	0.0650 - 0.3000
Beta	-0.03
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 15, 2026

About Kelyniam Global

Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors. The company was formerly known as Ketner Global Investments, Inc. and ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 20
• Stock Exchange: OTCMKTS
• Ticker Symbol: KLYG

Financial Performance

In 2023, Kelyniam Global's revenue was $2.67 million, a decrease of -11.44% compared to the previous year's $3.02 million. Losses were -$218,471, 123.9% more than in 2022.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 20, 2026

Data Sources Report a data error